IRIS
PELAIA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.923
AS - Asia 2.526
EU - Europa 1.209
SA - Sud America 930
AF - Africa 87
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.807
SG - Singapore 1.038
BR - Brasile 711
IT - Italia 611
CN - Cina 464
VN - Vietnam 450
IN - India 219
DE - Germania 167
HK - Hong Kong 117
AR - Argentina 89
GB - Regno Unito 81
FI - Finlandia 76
CA - Canada 49
MX - Messico 44
NL - Olanda 43
SE - Svezia 43
BD - Bangladesh 42
ID - Indonesia 42
EC - Ecuador 38
ES - Italia 28
IQ - Iraq 28
RU - Federazione Russa 28
FR - Francia 26
CO - Colombia 24
ZA - Sudafrica 23
VE - Venezuela 21
UA - Ucraina 19
AT - Austria 16
EG - Egitto 16
PY - Paraguay 16
PE - Perù 13
PL - Polonia 13
MA - Marocco 12
TR - Turchia 12
PK - Pakistan 11
CZ - Repubblica Ceca 10
IE - Irlanda 10
JP - Giappone 10
CL - Cile 9
DO - Repubblica Dominicana 9
NP - Nepal 9
TW - Taiwan 9
KE - Kenya 8
MY - Malesia 8
PH - Filippine 8
SA - Arabia Saudita 8
TN - Tunisia 8
UY - Uruguay 8
AU - Australia 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
UZ - Uzbekistan 6
DZ - Algeria 5
ET - Etiopia 5
JO - Giordania 5
CR - Costa Rica 4
EE - Estonia 4
IR - Iran 4
LT - Lituania 4
LV - Lettonia 4
PT - Portogallo 4
RO - Romania 4
AL - Albania 3
BG - Bulgaria 3
KG - Kirghizistan 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
CH - Svizzera 2
GR - Grecia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
EU - Europa 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MR - Mauritania 1
NE - Niger 1
NI - Nicaragua 1
PR - Porto Rico 1
Totale 7.682
Salva come PNG Salva come JPEG
Città #
San Jose 600
Singapore 391
Dallas 372
Ashburn 300
Ho Chi Minh City 194
Santa Clara 186
Chandler 179
Bengaluru 164
Hefei 160
Hong Kong 114
Munich 103
Hanoi 89
Beijing 86
Milan 78
Princeton 68
Lawrence 67
São Paulo 64
Chicago 62
Turku 52
Catanzaro 48
London 47
Wilmington 41
Boardman 38
Los Angeles 38
Naples 32
Haiphong 28
Palermo 27
Rome 25
Orem 22
Helsinki 21
Florence 20
Rio de Janeiro 19
Des Moines 18
Quito 18
San Nicola Manfredi 18
Council Bluffs 17
New York 17
Mexico City 16
San Francisco 16
Thái Bình 16
Amsterdam 15
Biên Hòa 15
Johannesburg 15
Ninh Bình 15
Baghdad 14
Bari 13
Guayaquil 13
Porto Alegre 13
Brasília 12
Buenos Aires 12
Redwood City 12
Warsaw 12
Alessandria 11
Belo Horizonte 11
Brooklyn 11
Chennai 11
Troina 11
Curitiba 10
Olomouc 10
Redmond 10
Salvador 10
Guarulhos 9
Lima 9
Norwalk 9
Ottawa 9
Paris 9
Seattle 9
Atlanta 8
Dublin 8
Galbiate 8
Hải Dương 8
Montreal 8
Thái Nguyên 8
Tokyo 8
Asunción 7
Da Nang 7
Denver 7
Hanover 7
Messina 7
Montevideo 7
Mumbai 7
Nairobi 7
The Dalles 7
Ankara 6
Bogotá 6
Boston 6
Can Tho 6
Castrovillari 6
Caxias do Sul 6
Manaus 6
Osasco 6
Phoenix 6
Ribeirão Preto 6
Stockholm 6
São Bernardo do Campo 6
São Luís 6
Taipei 6
Tashkent 6
Toronto 6
Aracaju 5
Totale 4.401
Salva come PNG Salva come JPEG
Nome #
Patient-derived 3D nasal spheroids reveal epithelial changes following Dupilumab therapy in CRSwNP: a preliminary report 151
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 124
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 96
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 96
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 89
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 79
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 78
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 75
Evaluation of a New Interface Combining High-Flow Nasal Cannula and CPAP 74
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 74
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 73
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 72
Type 2 severe asthma: pathophysiology and treatment with biologics 70
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 67
Association Between Sleep Apnea and Valvular Heart Diseases 67
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 66
MALDI MS-Based Investigations Targeting SARS-CoV-2 65
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 64
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 64
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 63
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 63
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study 63
Device for Performing Spirometry in Total Laryngectomized Patients 61
Clinical remission in severe asthma: lights and shadows on an ambitious goal 61
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 61
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 60
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 59
Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation. 59
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade 58
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 58
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 58
Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study. 58
Nasal polyposis: Insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells 58
Current Practice of High Flow through Nasal Cannula in Exacerbated COPD Patients 58
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 58
Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome 55
Nurse led protocols for control of glycaemia in critically ill patients: A systematic review 55
Biologics in severe asthma 55
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 54
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 54
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients 54
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 54
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 54
Switching Biological Therapies in Severe Asthma 53
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 53
Emerging biological treatments for asthma 53
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 53
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 53
Oxygenation strategies during flexible bronchoscopy: a review of the literature 53
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 53
Effect of continuous positive airway pressure on non-fatal stroke and paroxysmal atrial fibrillation recurrence in obstructive sleep apnoea elderly patients 53
Maxillary sinus mucocele with orbital complications 52
Patient-ventilator asynchrony in adult critically ill patients 52
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 51
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 51
Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis. 51
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 51
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 51
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies 50
Phenotyping severe asthma: a rationale for biologic therapy 50
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 50
Allergy clinics in times of the SARS-CoV-2 pandemic: An integrated model 49
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 49
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 49
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 49
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 49
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 49
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 49
Adherence to omalizumab: A multicenter “real-world” study 49
Tissue microRNA dynamics in sinonasal inverted papilloma: implications for pathology and therapy 48
Primary mucosal melanoma presenting with a unilateral nasal obstruction of the left inferior turbinate 48
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 47
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 47
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 47
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 47
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 46
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 46
What is the Role of Sex-Related Differences in the Effectiveness and Safety of Biological Drugs used in Patients' Severe Asthma? 46
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study 46
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma 46
Interleukin-5 in the Pathophysiology of Severe Asthma 46
Intrinsic laryngeal lipoma treated with transoral Co2 laser microsurgery: An unusual case report 46
Tezepelumab: A potential new biological therapy for severe refractory asthma 46
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 45
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 45
Influence of allergic status and nasal polyposis on long-term Benralizumab response in eosinophilic severe asthma 44
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life 44
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 44
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 44
Are Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from 8 Italian Centers 44
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 44
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers 43
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease 43
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 43
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 43
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 43
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 43
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab 42
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 42
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 42
Totale 5.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 10 5 4
2021/2022242 5 5 33 34 7 8 22 40 29 22 36 1
2022/2023625 141 33 41 25 61 56 26 54 85 30 52 21
2023/2024390 68 46 34 28 13 76 6 18 6 26 24 45
2024/20251.637 169 19 27 34 190 215 109 50 164 52 254 354
2025/20264.825 237 494 773 1.012 465 232 541 245 542 284 0 0
Totale 7.930